A Phase I Study of the Transplantation of Genetically Marked Autologous Bone Marrow Stromal Cells. University of Toronto, Ontario, Canada
- 1 March 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 9 (4) , 591-600
- https://doi.org/10.1089/hum.1998.9.4-591
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The TMC Worldwide Gene Therapy Enrollment Report, End 1996. Report of TMC Development, Paris, FranceHuman Gene Therapy, 1997
- Systemic Delivery of Human Growth Hormone or Human Factor IX in Dogs by Reintroduced Genetically Modified Autologous Bone Marrow Stromal CellsHuman Gene Therapy, 1997
- Arterial Gene Therapy for Restenosis. St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MassachusettsHuman Gene Therapy, 1996
- Biology of Bone Marrow StromaAnnals of the New York Academy of Sciences, 1995
- Cancer Gene Therapy Using Plasmid DNA: Purification of DNA for Human Clinical TrialsHuman Gene Therapy, 1995
- A Model for Predicting the Risk of Cancer Consequent to Retroviral Gene TherapyHuman Gene Therapy, 1992
- Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble formsCell, 1990
- Hemopoietic stromal microenvironmentAmerican Journal of Hematology, 1983
- Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in manNature, 1982
- Stromal cell associated haemopoiesisJournal of Cellular Physiology, 1982